Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research - United Kingdom
doi 10.1186/bcr51
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

SRC Family Protein Tyrosine Kinases Induce Autoactivation of Bruton's Tyrosine Kinase.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases

Journal of Cell Biology
MedicineCell Biology
2000English

Drug-Induced Ubiquitylation and Degradation of ErbB Receptor Tyrosine Kinases: Implications for Cancer Therapy

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2002English

Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Exploring Receptor Tyrosine Kinases-Inhibitors in Cancer Treatments

Egyptian Journal of Medical Human Genetics
Genetics
2019English

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2004English

Tyrosine Phosphorylation and Regulation of the AMPA Receptor by SRC Family Tyrosine Kinases

Journal of Neuroscience
Neuroscience
2004English

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy